Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Surfaxin lucinactant: Phase III; pivotal Phase III ongoing

In an international Phase III study in 252 premature infants, Surfaxin was non-inferior to Curosurf pig

Read the full 166 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE